Vetter Dedicates New Facility in Suburban Chicago
Skokie, Illinois
With the dedication today of its new 24,000-square-foot facility at the Illinois Science + Technology Park in Skokie, Vetter may enable life-sciences firms to streamline their early development process and cut time to market. Vetter, a contract manufacturer, produces aseptically pre-filled injection systems including syringes, vials and injection pens and is mainly engaged in the field of fill and finishing of compounds indicated for conditions such as cancer, Parkinson’s disease, and inflammatory and autoimmune disorders. Vetter also manufactures its customers´ vaccines, including that for the H1N1 virus.
Operational by the end of 2010, the Skokie facility will focus exclusively on pre-clinical through Phase IIb projects and will fill very small quantities of product, required for early studies. For Phase III the projects will be transferred to the company’s German facilities for large-scale production. The new facility to be located in Chicago, IL.
“Since nearly half of our customer base is located in North America, creating a U.S. facility was the logical next step,” said Peter Soelkner, Vetter`s managing director.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
